1. GlaxoSmithKline Pharma
GlaxoSmithKline Pharma Share Price

GlaxoSmithKline Pharma Share Price

NSE: GLAXO

|

BSE: 500660

|

Pharmaceuticals

75% Buy

₹3,227.80

+₹56.40 (1.78%) Last updated on 24 Jun, 2025 | 09:53 IST

GlaxoSmithKline Pharma Overview

Market cap
Market Cap Switch₹53,725 Crs
Open
₹3,186.00
Prev. Close
₹3,171.40
Circuit range
₹3,805.60 - ₹2,537.20
Day range
₹3,186.00 - ₹3,240.50
Year range
₹1,921.00 - ₹3,515.70
Volume
14,389
Avg. traded
₹3,216.91
Revenue (12m)
₹3,749 Crs

About GlaxoSmithKline Pharma

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.
  • Chart
  • Fundamentals
  • Financials
  • Shareholdings
  • Events
  • Peers
  • News
  • FAQs

GlaxoSmithKline Pharma Share Price Chart

Please wait...

GlaxoSmithKline Pharma Key Indicators

P/E ratio
58.18
P/B ratio
29.81
ROE
48.92%
ROCE
66.95%
Dividend yield
1.56%
Debt/Equity ratio
EPS
54.25

Investment Checklist: (4/6)

passed

Equity returns

not passed

Dividend returns

passed

Safety factor

NA

Growth factor

passed

Debt vs Equity

passed

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst Ratings:

Buy

Buy

75%

Hold

25%

Sell

0%

This analysis is based on the reviews of 4 experts in the last 7 days

GlaxoSmithKline Pharma Financial Ratios

  • Profitability

  • Operational

  • Valuation

Operating profit margin

32.02%

Net profit margin

22.43%

ROE

48.92%

ROA

24.97%

ROCE

66.95%

GlaxoSmithKline Pharma Shareholder returns

1 day
+0.45%
1 week
-2.47%
1 month
+15.32%
3 months
+12.34%
1 year
+27.02%
3 years
+113.06%
5 years
+134.94%

Revenue Statement

All values are in ₹ Crores (Cr)
RevenueNo Sort
Operating ProfitNo Sort
Net ProfitNo Sort
Mar-25
3,749.21
1,323.29
927.58
Mar-24
3,453.71
1,031.28
589.96
Mar-23
3,251.72
904.95
607.64
Mar-22
3,278.03
837.65
380.77

Cash Flow

All values are in ₹ Crores (Cr)
OperatingNo Sort
InvestingNo Sort
FinancingNo Sort
Mar-25
1,289.90
-45.8
-769.42
Mar-24
582.02
8.71
-561.50
Mar-23
484.23
807.85
-1543.32
Mar-22
810.75
-405.51
-524.24

Balance Sheet

All values are in ₹ Crores (Cr)
Total AssetNo Sort
Total LiabilityNo Sort
Mar-24
3,410.31
1,632.67
Mar-23
3,193.04
1,451.77
Mar-22
4,520.13
1,857.17
Mar-21
3,011.52
1,533.26

GlaxoSmithKline Pharma Share Price History

DayOpenCloseChange %
23-Jun-25
₹3,176.50
₹3,171.40
-1.31%
20-Jun-25
₹3,190.20
₹3,213.50
+0.45%
19-Jun-25
₹3,250.00
₹3,199.20
-2.65%
18-Jun-25
₹3,240.10
₹3,286.40
+1.00%
17-Jun-25
₹3,344.00
₹3,254.00
-3.35%
16-Jun-25
₹3,285.70
₹3,366.80
+2.18%
13-Jun-25
₹3,300.00
₹3,295.00
-0.75%
12-Jun-25
₹3,398.00
₹3,320.00
-1.72%

GlaxoSmithKline Pharma Shareholding Pattern

CategoryMar 2025Dec 2024Sep 2024Jun 2024
Promoters
75.00%
75.00%
75.00%
75.00%
Foreign institutions-FII
4.52%
4.50%
4.36%
4.02%
Other domestic institutions
2.62%
2.34%
2.35%
2.79%
Retail and other
12.69%
13.19%
13.30%
13.48%
Mutual Funds
5.17%
4.96%
4.98%
4.71%

Corporate Actions

  • Dividend • ₹42/share

    Ex date 30 May 2025

    expand tab
  • Dividend • ₹12/share

    Ex date 07 Nov 2024

    expand tab
  • Dividend • ₹32/share

    Ex date 31 May 2024

    expand tab
  • Dividend • ₹32/share

    Ex date 30 Jun 2023

    expand tab

Stocks Similar to GlaxoSmithKline Pharma

PriceNo Sort
Change %No Sort
Abbott India₹31,290.00+₹240.00 (0.77%)
Ajanta Pharma₹2,566.40+₹1.50 (0.06%)
Alkem Laboratories₹4,786.50+₹26.50 (0.56%)
Aurobindo Pharma₹1,111.70+₹12.00 (1.09%)
Laurus Labs₹670.10+₹3.80 (0.57%)
Lupin₹1,949.00+₹21.80 (1.13%)
Pfizer₹5,616.50-₹23.00 (-0.41%)
Sanofi India₹6,019.50-₹7.50 (-0.12%)

Popular Stocks

PriceNo Sort
Change %No Sort
HDFC Bank₹1,961.10+₹12.70 (0.65%)
Hindustan Unilever₹2,284.30+₹9.20 (0.40%)
Infosys₹1,589.30+₹5.30 (0.33%)
ITC₹416.60+₹2.70 (0.65%)
ITC HOTELS LIMITED₹215.39+₹3.36 (1.58%)
JIO FIN SERVICES LTD₹301.20+₹8.05 (2.75%)
Reliance₹1,463.80+₹7.00 (0.48%)
Tata Motors₹679.40+₹8.15 (1.21%)
Tata Power₹398.45+₹5.45 (1.39%)
Tata Steel₹154.08+₹1.65 (1.08%)

FAQs on GlaxoSmithKline Pharma

What is the share price of GlaxoSmithKline Pharma today?

chevron-up
GlaxoSmithKline Pharma share price is ₹ 3,227.80 as on 24 Jun, 2025 | 09:53 IST.

What are the high & low stock price of GlaxoSmithKline Pharma today?

chevron-up
GlaxoSmithKline Pharma stock price hit a high of ₹ 3,240.50 and low of ₹ 3,186.00 as on 24 Jun, 2025 | 09:53 IST.

What is the market cap of GlaxoSmithKline Pharma?

chevron-up
The market cap of GlaxoSmithKline Pharma is ₹ 53,725.43 Crores as on 24 Jun, 2025 | 09:53 IST.

What are the the 52-week high and low share prices of GlaxoSmithKline Pharma stock on the NSE?

chevron-up
52-week high stock Price of GlaxoSmithKline Pharma is ₹ 3,515.70 and Low Price is ₹ 1,921.00 as on 24 Jun, 2025 | 09:53 IST.

What are the stock symbols of GlaxoSmithKline Pharma?

chevron-up
The stock symbol of GlaxoSmithKline Pharma is NSE: GLAXO on the NSE, BSE: 500660 on the BSE, and the ISIN is INE159A01016.

Can I buy GlaxoSmithKline Pharma shares on Holidays?

chevron-up
No, shares of GlaxoSmithKline Pharma or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell GlaxoSmithKline Pharma shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.

What is the PE and PB ratio of GlaxoSmithKline Pharma?

chevron-up
The PE and PB ratio of GlaxoSmithKline Pharma is 58.18 and 29.81 respectively, as on 24 Jun, 2025 | 09:53 IST.

What are the returns on GlaxoSmithKline Pharma shares?

chevron-up
The historical returns for GlaxoSmithKline Pharma shares are 27.02 for 1 year, 113.06 for 3 year and 134.94 for 5 year.